Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients

Cancer immunology—analysis of host and tumor factors for personalized medicine

(2011) Shuji Ogino et al.   Nature Reviews Clinical Oncology

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site

(2011) Jinbin Xu et al.   Nature Communications

Proteomic analysis of the transitional endoplasmic reticulum in hepatocellular carcinoma: An organelle perspective on cancer

(2010) Line Roy et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Implications of the tumor microenvironment on survival and disease response in follicular lymphoma

(2010) John G Gribben   CURRENT OPINION IN ONCOLOGY

MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis

(2010) Sonja I Buschow et al.   IMMUNOLOGY AND CELL BIOLOGY

Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity

(2010) Ikhlas S. Ahmed et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Progesterone Receptor Membrane Component 1 (Pgrmc1): A Heme-1 Domain Protein That Promotes Tumorigenesis and Is Inhibited by a Small Molecule

(2010) I. S. Ahmed et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression

(2010) J.J. Peluso et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Progesterone Receptor Membrane Component 1 Inhibits the Activity of Drug-Metabolizing Cytochromes P450 and Binds to Cytochrome P450 Reductase

(2010) E. Szczesna-Skorupa et al.   MOLECULAR PHARMACOLOGY

Circulating tumour-derived microvesicles in plasma of gastric cancer patients

(2009) Jaroslaw Baran et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Progesterone Receptor Membrane Component-1 Regulates the Development and Cisplatin Sensitivity of Human Ovarian Tumors in Athymic Nude Mice

(2009) John J. Peluso et al.   ENDOCRINOLOGY

Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis

(2009) Ikuo Kimura et al.   JOURNAL OF NEUROCHEMISTRY

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

(2009) A F Gazdar   ONCOGENE

Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure

(2008) Mahmoud Reza Mansouri et al.   HUMAN MOLECULAR GENETICS

Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1

(2008) John J. Peluso et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story

(2007) Lecia V. Sequist et al.   Annual Review of Medicine

Progesterone Receptor Membrane Component-1 (PGRMC1) Is the Mediator of Progesterone’s Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells As Revealed by PGRMC1 Small Interfering Ribonucleic Acid Treatment and Functional Analysis of PGRMC1 Mutations

(2007) John J. Peluso et al.   ENDOCRINOLOGY